期刊文献+

贝伐珠单抗治疗非小细胞肺癌脑转移伴顽固性瘤周水肿的临床分析 被引量:7

Efficacy of bevacizumab in the treatment of brain metastases with intractable peritumoral edema in non⁃small cell lung cancer
原文传递
导出
摘要 脑转移是肺癌患者的常见并发症和主要死亡原因之一,发生率为30%~50%。,自然病程少于3个月。除了恶性转移瘤的占位效应以外,转移瘤伴随的瘤周水肿(peritumoral brain edema,PTBE)会导致患者颅内压增高,引起头痛、头晕等一系列临床症状,严重影响患者生存质量。
作者 杨三虎 高红祥 崔立春 畅婕 李瑶 魏娜 杨拴盈 杜建飞 Yang Sanhu;Gao Hongxiang;Cui Lichun
出处 《中华肺部疾病杂志(电子版)》 CAS 2020年第5期676-678,共3页 Chinese Journal of Lung Diseases(Electronic Edition)
  • 相关文献

参考文献1

二级参考文献11

  • 1Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wang E, et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res 2012;17:25.
  • 2Williams B J, Park DM, Sheehan JP. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurg 2012;116:972-7.
  • 3Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC. Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: A pilot study. Stereotact Funct Neurosurg 2008;86:359-66.
  • 4Friedman HS, Prados MD, Wen PY, Mikkelsen T, SchiffD, Abrey LE, et aL Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 2009;27:4733-40.
  • 5Yoshida M, Goto M, Kii T, Nishitani H, Kawabe S, Kuwakado S, et al. Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer. Digestion 2013;87:59-64.
  • 6Nagane M, Nishikawa R, Narita Y, Kobayashi H, Takano S, Shinoura N, et al. Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma. Jpn J Clin Oncol 2012;42:887-95.
  • 7Besozzi G, Ferrara A, Epifani E, Intini D, Apruzzese M, Provenzano A, et al. Acute stroke after intravitreal bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasficum: A severe systemic adverse event after an off-label procedure. Int Ophthalmol 2013;33:181-3.
  • 8Campbell ILl, Bell CM, Paterson JM, Bronskill SE, Moineddin R, Whitehead M, et al. Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: A time series analysis. Ophthalmology 2012; 119:1604-8.
  • 9Campbell RJ, Gill SS, Bronskill SE, Paterson JM, Whitehead M, Bell CM. Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: Nested case-control study. BMJ 2012;345:e4203.
  • 10Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM. Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol 2011 ; 105:281-9.

共引文献6

同被引文献70

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部